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Environmental Toxicology of
Polychlorinated Dibenzo-p-Dioxins and
Polychlorinated Dibenzofurans
by John R Vanden Heuvel"2 and George Lucier
Fewenvironmentalcompoundshavegenerated asmuch interest andcontroversy withinthescientificcommunityand
inthe lay public as polychlorinated dibenzo-p-dioxins (PCDDs)and polychlorinated dibenzofurans (PCDFs). Theirubi-
quitous presenceintheenvironmentandtheriskofaccidental exposurehasraisedconcernoverapossiblethreatofPCDDs
or PCDFs tohuman health. The most extensively studiedand potentisomeris2,3,7,8-tetrachlorodibenzo--dioxin (TCDD
ordioxin). Dioxin is amultisitetoxicant inlaboratory rodents resulting in anumberoftissue-, species-,andsex-dependent
responses. Muchhasbeenlearnedaboutthemechanismofdiodn'seffects,especially fortheinductionofcytochrome P-450
enzymes. Binding ofPCDDs and PCDFs to a receptor protein, termed the dioxin or Ah receptor, is necessary for most
biologcal andtoxic responses. The most conmontoic responseusedforevaluatingthehunanhealthriskposedby PCDDs
and PCDFsisthehepatocarcinogenic responseobserved primarily inrodents. Despiteextensiveresearchefforts, theef-
fectsofPCDDsand PCDFs on humans are notwellcharacterized. However, available dataindicate thereisgood agree-
mentbetweenknowneffectsofdioxininlaboratory animalsandthosedescribedinepidemidologicalstudiesforeffectsin
humans. The sequence in events initiated by the Ah receptorinteracting with dioxin-responsive genes andending with
altered patternsofdifferentiationandgrowth mustbesoughtinordertounderstandtissue, species, sex, andinterindividual
variation in biological responses and the health risk posed by PCDDs and PCDFs.
Introduction
Over the past20-30 years thepublic has become increasing-
ly aware ofthe presenceoftoxic substances intheenvironment
and the risk that these substances pose to human health. The
polychlorinated dibenzo-p-dioxins (PCDDs) and polychlori-
nateddibenzofurans (PCDFs) aretwoseriesofpolychlorinated
aromatic compounds (Fig. 1) that areubiquitous environmental
contaminants. Ofthe 75 possible PCDDs and 135 PCDFs, the
most extensively studied isomer is 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD), commonly referred to asdioxin. Since 1970,
ithasbeenestimated that morethan$1 billionhasbeen spent on
researching the toxicity ofPCDDs and PCDFs. These studies
have produced considerable information on the properties and
mechanism of action of PCDDs and PCDFs, yet there is no
agreement by the health authorities on the risks posed by these
substances.
Inlaboratory animals, dioxinis oneofthe mosttoxicchemicals
ever described. The spectrum of toxic responses observed in
rodents includes effects on immune function, reproduction,
organogenesis, lipid andglucose metabolism, and behavior (1).
In addition, TCDD is a multisite carcinogen in rodents and is
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FIGURE 1. Structures of polychlorinated dibenzo-p-dioxins (top) and poly-
chlorinateddibenzo-p-furans (bottom).
classified asatumorpromoterinliverand skin. Thehepatocar-
cinogeniceffects inrodentshavebeentheprimaryendpointused
toestimatehumanhealthriskassociatedwithexposuretothese
compounds. However, duetothevarietyofquantitative models
used todescribe the sameexperimental data sets, an unusually
large range of health risk estimates has been proposed by
regulatoryagenciesthroughouttheworld(Table 1). Inaddition,
theestimatedhumanconsumptionofdioxinsandfurans(approx-
imately 1 pg/kg/day) is close tothetolerabledaily intake setby
the health authorities in several countries.
Concedingthathumansareexposedtosignificant amountsof
PCDDsandPCDFs intheirday-to-dayexistence, the next issue
facedby scientists istodeterminetheriskposedbythisexposureVANDENHEUVELANDLUCIER
Table 1. Extrapolation to humans from chronic animal studies with TCDD by various health agencies.a
Agency Mechanistic basis ofextrapolation Results
U.S. EPA Nonthreshold, linearized multistage model (dose/surface area) VSD = 0.0064 pg/kg/day
U.S. CDC Nonthreshold, linearized multistage model (liver concentration) VSD = 0.0276 pg/kg/day
U.S. FDA Nonthreshold, linearized multistage model (dose/body weight) VSD = 0.0572 pg/kg/day
Germany Threshold, safety factorapplied to NOAEL Maximal daily intake 1-10 pg/kg/day
U.K. Department ofthe Environment Threshold, safety factorapplied to NOAEL Allowable daily intake 1-10 pg/kg/day
Dutch Institute ofNatural Health Threshold, safety factorapplied to NOAEL Allowable daily intake 4 pg/kg/day
Swiss Institute ofToxicology Threshold, safety factorapplied to NOAEL Allowable daily intake 10 pg/kg/day
Ontario Ministry ofthe Environment Threshold, safety factorapplied to NOAEL Allowable daily intake 10pg/kg/day
Abbreviations: EPA, Environmental Protection Agency; CDC, Centers forDiseaseControl; FDA, Food and Drug Administration; NOAEL, noobservable adverse
effect level; VSD, virtually safe dose for upper-limit cancerrisk of 10-.
aSource ofthe dose-response data is a 2-year study by Kociba et al. (67).
as well as incremental exposures over background levels. The
purpose ofthe presentarticle is to review theknowledge gained
on the toxicity and mechanism ofaction ofthese important en-
vironmental contaminants. Theappropriateness ofextrapolating
dataobtained from laboratory animals tohumansandthe useof
dose-response relationships is also discussed.
Sources and Environmental Fate of
PCDDs and PCDFs
Sources
There are nospecificcommercial uses forPCDDs orPCDFs,
and they ariseprimarily as unwantedcontaminants. An impor-
tant aspect intheevaluation ofhealth risksassociatedwithdioxin
and related compounds is thatthey often exist as complex mix-
tures of polychlorinated species including polychlorinated
biphenyls (PCBs), polychlorinated phenols, andpolychlorinated
tetraphenyls. Therefore, itisoftendifficult todissociate therisk
posed by trace contaminants such as dioxin from those species
present in much higher proportions.
Theprimary sourcesofthesecontaminants includeschemical,
enzymatic, thermal, andphotochemical reactions (Table 2). It
has been suggested that PCDDs and PCDFs are almost ex-
clusively ofanthropogenic origin (2), although forest fires may
resultintheirformation aswell (3). Aseriesofcombustion reac-
tions have been found to result in the formation ofPCDDs and
PCDFs. The formation ofPCDDs and PCDFs from waste in-
cineration has been recognized for several years based on their
determination infly ash (3). PCDDsandPCDFs may form as a
result ofburning precursor products, i.e., chlorophenol com-
pounds, or as a result ofpyrolysis ofunrelated chlorine com-
pounds (1). Several factors determine the relative amount of
PCDDandPCDFformedbycombustionoforganicmaterialsin-
cludingchlorine contentofthe fuel, mixing efficiency withair,
and reactiontemperature. Inaddition, theamountofleadpresent
in petrol products is directly related to the formation ofthese
chemical species(4). Very lowlevelsofPCDDsandPCDFshave
beenobserved incigarettesmokeandcharcoal-grilled meats(5).
One source of aquatic dioxin contamination is the result of
chlorine bleaching of paper pulp (6). Sediment analysis per-
formed inthevicinity ofpapermillsusing this process showhigh
levels ofTCDDandTCDF, as well aslesserchlorinateddioxins
and furans (6). In addition, contamination of water and fish
downstream from paper mills has been observed. Recent con-
cern overthepresence ofthese contaminants inbleached paper
products has surfaced due to low levels ofPCDDs and PCDFs
found in coffee filters, facial tissue, and milk cartons.
Table2. SourcesofPCDDs and PCDFs.a
Thermal processes
Incinerationofmunicipal solid waste
Production ofsteel and copper
Combustion ofleaded gasoline
Accidental burning ofPCB-containing electrical equipment
Incineration ofcoal, peat and wood
Cigarette smoke
Chemical processes
Chlorine bleaching ofpaperproducts
Intermediates in production ofchlorophenol-based products
Abbreviations: PCDD, polychlorinated dibenzo-p-dioxin; PCDF, polychlorin-
ated dibenzofuran; PCB, polychlorinated biphenyl.
aAdapted from Rappe (2).
The presence of PCDDs and PCDFs as impurities in the
manufactureofchlorophenolandchlorinatedaromatichydrocar-
bons has added to the public concern about these substances.
Chlorophenolsarewidelyusedasfungicides andherbicidesand
are key intermediates in the production ofphenoxyacetic acid
herbicides suchas2,4,-dichlorophenoxyacetic acid(2,4-D)and
2,4,5-trichlorophenoxyacetic acid (2,4,5-T). The herbicide
knownas "AgentOrange" usedasadefoliantinVietnamisa 1:1
mixture of n-butyl esters of 2,4-D and 2,4,5-T and is con-
taminatedwithupto30mg/kgwith2,3,7,8-TCDD. PCBsused in
electrical transformers andcapacitors have also been shown to
be contaminated with high levels ofPCDFs.
Fate in Environment
PCDDsandPCDFsarestronglyboundtoorganicmatterinthe
environment. These compounds have a high degree ofhydro-
phobicity thatgenerally increases with thedegreeofchlorina-
tion. Duetothestrengthofthisbinding, 2,3,7,8-TCDDisusually
found in uppermost layers ofthe soil and undergoes very little
vertical migration(1). Transportofthesechemicalsisgeneral-
lygovernedbythemobilizationofsoilparticlestowhichthey are
attached. LevelsofPCDDsandPCDFsinaqueousenvironments
isgenerallylowduetopreferentialabsorptiontoparticulatemat-
ter. However, suspension ofthis particulate matter may occur.
Animalslivinginthisenvironmentmaybecomeexposedtothese
chemicals either directly, i.e., by ingestion of contaminated
sediment, or indirectly, i.e., through the food chain. Bioac-
cumulation of PCDDs and PCDFs in aquatic biota is highly
dependentonthechemicalspeciesinvolvedaswellastheanimal
exposed (6).
Photolysisappears tobe theprimary routeofenvironmental
degradation of PCDDs and PCDFs. Exposure of dioxins to
ultraviolet light in thepresence ofanelectrondonor [e.g., leaf
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waxes, organic films, pesticides, andotherco-pollutants (1,7,8)]
results inthedegradationofTCDD. Very fewbacterial orfungal
species are known todegradedioxins. Thehalf-lifeofTCDD in
soil in the absence of UV light is approximately 10 years,
indicating thegeneral lackofalternativedegradationpathways.
Human Exposure
Due to the numerous sources and the environmental persis-
tence ofPCDDs and PCDFs, these classes ofcompounds have
ubiquitous distribution. Perhaps the earliestclinical description
ofdioxin toxicity inhumans was in 1901 (9) whenthe skin con-
ditionchloracne, the mostapparenttoxic responseofhumans to
PCDDS and PCDFs, was reported. The primary exposure of
humans totheselipophilic compoundsisviathefoodchain(10).
Approximately 90% of the total daily intake of PCDDs and
PCDFs isderived from food, particularlythoseofanimal origin.
Another important source of contamination may be from
packaging materials (10). The average daily intake via food in
industrial countries has been estimated to be in 1-3 pg PCDDs
and PCDFs/kg body weight/day. This level of consump-
tion is higher than that recommended by the U.S. EPA as a
"safe" level (1 in 1,000,000 cancer risk) of exposure (0.006
pg/kg/day).
Monitoring human tissues for the presence ofPCDDs and
PCDFs indicates thatthere arebackground levels ofthese com-
pounds. The average levels of dioxin in human tissues are
generallyhigherin industrial countriesthanthosefromdevelop-
ing nations (Table 3). Within agiven country, thehumantissue
levels aregenerally consistent, although Vietnam may bethe ex-
ceptionduetothehighlevel exposuretoPCDDsandPCDFs as
a result of Agent Orange contamination. The tissue levels of
PCDDs and PCDFs can be substantially elevated in poisoning
cases. Several high-level exposures ofdioxins havebeenreported
inhumanssuch asthetoxicriceoiloutbreakinTaiwanandJapan,
theBASFplantexplosioninGermany, theSevasoincident inIta-
ly, Agent Orange exposure in Vietnam,and the Missouri waste
oil contamination in the United States [for review see Skene et
al. (1)]. Due to the slow metabolism ofPCDDs and PCDFs in
humans (half-life 5-10years) andsequestration inadipose tissue
and liver, the body burden of these compounds can remain
elevated for years after exposure.
Mechanism of Action of PCDDs
and PCDFs
DiscoveryofAh Receptor
The striking similarity in the biological effects of several
polychlorinatedcompounds such asPCDDS, PCDFs, PCBsand
polybrominated biphenyls (PBBs) leadGloverandPoland (12)
tohypothesizethatthesexenobiotics elicittheireffectsthrough
a common mechanism. Theunusual potency ofTCDD and the
relationship between congener structureand potency were im-
portantcluesthathalogenatedhydrocarbons may actthrough a
specific receptor(s). This receptor was subsequently character-
ized, and itsproperties are discussedbelow.
The administration of 3-methylcholanthrene (3-MC) and
structurally relatedpolycyclicaromatichydrocarbons to some in-
bredstrainsofmiceleadstotheinductionofcytochrome P-450
andassociated monooxygenaseactivities [i.e, arylhydrocarbon
hydroxylase(AHH) andethoxyresorufin-O-deethylase (EROD)
activity]. Inthefollowingdiscussion, these enzymeswillbecall-
edby their recommendednomenclature, i.e., Cyprepresenting
cytochrome P-450, followed by an arabic numberdenoting the
familyand alettertodesignatethesubfamily (13). Theinduction
ofAHH activity by PCDDs and PCDFs is a resultofincreased
CyplAl. Subsequently, AHH aswell asERODactivites willbe
described intermsoftheformofcytochrome P-450associated
with their activity, CyplAl.
Early studiesofgenetic polymorphisms inmiceshowed that
3-MC induced CyplAl in C57BL/6 ("responsive") but not
DBA/2 ("nonresponsive") inbred mouse strains (14). Cross-
breeding studies showed that the responsive phenotype, i.e.,
3-MC induction ofCyplAl, segregated as adominanttrait and
was governedby a singleautosomal gene. The gene locus con-
trolling this trait is designated the Ah (for arylhydrocarbon)
locus. Mouse strains that are nonresponsive to 3-MC are less
sensitive to TCDD aswell. Polandetal. (15) subsequentlyiden-
tifiedandcharacterized areceptorprotein forTCDD, 3-MC, and
other inducers of CyplAl in C57BL/6J mice. This protein
(designatedtheAh ordioxinreceptor)isapparently aproductof
theAhlocus(16). DiscoveryoftheAhreceptor was asignificant
event in thematurationoftoxicology as ascientificdisciplineand
also helped to find a common focus for the disciplines oftox-
icology andmolecularbiology.
Table3. Backgrund PCDDand PCDFlevels inhumantissues.'
Country
Tissue USA Germany China Japan Canada S. Vietnam N. Vietnam
Blood
Total PCDDs 1499 788 1983 126
Total PCDFs 92 98 133 41
PCDDs + PCDFs 1591 886 2071 167
Adipose tissue
Total PCDDs 558 942 247 1535 1217 814 133
Total PCDFs 32 140 53 92 65 57 21
PCDDs + PCDFs 590 1082 300 1627 1282 871 154
Milk
Total PCDDs 367 289 1085 493 406 104
Total PCDFs 31 58 44 41 133 23
PCDDs + PCDFs 398 348 1128 534 559 127
Abbreviations: PCDD, polychlorinated dibenzo-p-dioxin; PCDF, polychlorinated dibenzofuran.
aData are expressed as average parts pertrillion relative to lipid content. Adapted from Schecter(11).
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Role ofAh Receptor inBiological Responses to
PCDDs and PCDFs
Presenceofthe Ah receptorconferssensitivity toseveralofthe
effectsofPCDDsandPCDFsincludingenzymeinduction, car-
cinogenesis, and immunotoxicity. Mason and Okey (17)
demonstratedthatinseveraltissues, nuclearAhreceptorlevels
werehigher inresponsiveC57BL/6Jmicethaninnonresponsive
DBA/2J mice. This is consistent withthe factthatPCDDs and
PCDFselicitbiological responses inboth strainsofmice, albeit
atdifferent dose levels. Inaddition, inseveral mammalian cell
culture systemthere isanexcellentcorrelationbetweenCyplAl
induction (AHH activity) andnumberofAh receptormolecules
per cell (18).
Althoughthese data supportreceptor-mediated specificity of
biological responses, thepresence ofthe Ah receptor by itself
cannotexplainobservedspeciesandtissuedifferences intheef-
fects ofPCDDs and PCDFs. HepaticAh receptorlevels andKd
values for [3H]2,3,7,8-TCDD binding in several species, (i.e.,
pigs, rats, hamsters, andnonhumanprimates), arecomparable,
althoughtherearemarkeddifferencesinmaximalCyplAl induc-
tion andtoxicity (18). Forexample, despite similar Ahreceptor
characteristics, theacutelethality andmaximal CyplAl induc-
tionbydioxinvariesovera5000-foldrangebetweentheguinea
pig and the hamster (19). Also, there is little difference in Ah
receptorconcentrationinvariousrodenttissues(20). Therefore,
although the presence of the Ah receptor is necessary for
biochemical andbiological responses toPCDDsandPCDFs, it
is not sufficient to explain the qualitative and quantitative dif-
ferences in biological response. Recently, Denison et al. (21)
haveshownthatalthoughAhreceptorlevelsdonotcorrelatewith
tissueand species responses todioxin, thereisgoodagreement
between the binding of the TCDD-Ah receptor complex to
specific segments ofDNAandresponsiveness ofthatcelltoen-
zyme induction by dioxin. Hence, thereareotherpotential sites
ofregulationofthecell-specific responsestodioxinsandfurans
not solely governed by the concentration ofthe Ahreceptor.
Properties ofAh Receptor
TheAhreceptorisahigh-molecularweight(110-150KD)pro-
tein with reversible, high-affinity binding forTCDD [Kd0.1-0.4
nM (22)]. Thisbinding canbecompeted forby otherinducers
of CyplAl but not by inducers of other forms ofcytochrome
P-450 such asphenobarbital (23) orthesteroidsdexamethasone,
progesterone, estradiol, ortestosterone(15). Inaddition, TCDD
isnotaligandforanyidentifiedsteroidhormonereceptors. The
Ahreceptorissimilarinits structureandmechanism toknown
steroid receptors, although no steroidorendogenous ligandhas
been found. TheAhreceptorismarkedly similaramongspecies
examinedwitha5Ssedimentationcoefficientonsucrosedensity
gradientsandastokesradiusof6.6nm. Thereceptorisheatlabile
and inactivated by trypsin(24).
TheontogenyoftheAhreceptorhasbeenexamined inseveral
rodentspecies (25,26). ReceptorlevelsandpeakCyplAl induc-
tioninlungandliverincreasedpostpartum, reachingamaximum
by 15-21 days anddecliningthroughadulthood. Incontrast, Ah
receptor levelsinthethymusremainedconstantthroughoutthe
study. Theexpressionofthisreceptorproteindoesnotappearto
beregulatedbyendogenoushormones, asorchiectomy, ovariec-
tomy, adrenalectomy or hypophysectomy had no effect on Ah
receptor concentrations. However, it has been noted that
2,3,7,8-TCDD may induce hepatic Ah receptor levels (27).
Structure-Activity Relationships
Sincetheinitial studiesby Polandetal. (15) several otherin-
vestigators haveexaminedtheeffectofchlorine substitution on
Ah receptor binding and CyplAl induction [reviewed in Safe
(18)]. The results ofthesestudies are summarizedin Figure 2.
WithPCDDs, lateralchlorination(positions2,3,7,8)isquiteim-
portant for high-affinity binding to the receptor, whereas
chlorination atnonlateral positions (1,4,6,9) decreasesbinding
interaction with the receptor protein. Addition ofchlorines at
nonlateralpositions inhighlychlorinatedPCDDsmaydecrease
receptor binding by altering molecular size, lipophilicity,
coplanarity, oraromaticringelectrondensity. Similareffectsof
chlorinesubstitutionarenotedwithPCDFs, wherethemostac-
tivecongenersarefullysubstitutedinthe2,3,7, and8positions.
It has been suggested that a planar ring structure and an ideal
ligand binding area of3 x 10 A arecritical structural features
contributingtothehighbinding affinities of2,3,7,8-TCDD and
-TCDF (24,28).
Ah Receptor-Mediated Gene Regulation
Themechanismofactionofdioxinandrelatedcompounds
has been an area of intense scientific study [for review see
Whitlock(29)]. TheinductionofCyplAl iscommonlyusedas
the model system for TCDD's mechanism ofgene regulation,
althoughotherproteinshavebeenshowntobeunderdirectcon-
troloftheAhreceptor. AssummarizedinFigure3,theinduction
ofCypAl requiresmultipleevents, manyofwhichmaybeunder
tissue- and species-specific regulation. As discussed above,
TCDDandrelatedcompoundsenterthecellthroughpassivedif-
fusion andbind to the Ah receptor, presumably in the cytosol.
Similartohormonereceptors, uponligandbindingthereceptor
undergoes atransformation oractivationstep. TheAhreceptor
existsinitsinactivatedformasalargeproteincomplexcontaining
both 95 kD ligand binding and heat shock protein(s) [HSP 90
(30,31)]. ActivationoftheAhreceptormayinvolvedissociation
of these heat shock proteins following the binding ofTCDD.
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FIGURE 2. Summaryoftheeffectsofchlorine substituents ondifferentposi-
tioninthedibenzo-p-dioxin (top)anddibenzo-p-furanringsonthe relative
bindingtotheAh receptor. The(+) indicatesthatadditionofachlorine in-
creasesaffinity forthereceptor; (-)denotes adecrease inaffinity. Adapted
from Safe(18).
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FIGURE 3. Proposed mechanism of action of polychlorinated dibenzo-p-
dioxins andpolychlorinated dibenzofurans. Ligand (L)passively entersthe
cell and encounters and binds to the Ah receptor (AhR). This ligand-AhR
complex undergoes a structural transfornation (or activation) followed by
translocation to the nucleus. The activated receptorcomplexthen recognizes
and binds to specific regions (dioxin-responsive elements orDREs) 5' to a
dioxin-responsive gene. Binding to DREs results in an increase in gene
transcription ofseveral genes. The transcribed mRNA is translated in the
cytosol resulting inthe synthesisofcytochrome P-450s(primary biological
responses) aswell as amultitudeofotherbiological responsessuch asaltered
patterns ofgrowth and differentiation.
Subsequent to receptortransformation, nucleartranslocation of
the TCDD-AhR complex occurs before binding to DNA.
Recently thecDNA and partofthe genefor a87kDhuman pro-
tein required for nuclear translocation of the ligand-binding
subunit has been cloned andnamedtheamt(Ah receptornuclear
translocation) protein (29). In the ligand-bound form, the
nuclear Ah receptor functions as a trans-activator of several
genes including CyplAI (1). Theactivatedligand-bound recep-
torbinds to a core DNA recognition motiffound within several
enhancers, designated asdioxinresponsive elements (DREs). In
addition to inductionofcytochromesCyplAl andCyplA2,other
primarybiological responses includeinductionofglutathione-S-
transferase, menadioneoxidoreductase, andaldehydedehydro-
genase. Using a subtractive hybridization technique, a recent
study has shownthatplasminogen activator inhibitor-2 (PAI-2)
and a yet unidentified clone are induced at the level of gene
transcription by TCDD (33).
Primary biological responses such as those described above
may result in secondary and tertiary effects. Many secondary
biological responses exist due to dioxin's perturbation of en-
docrine systems, i.e., hormones and hormone receptors. Diox-
inandstructuralanalogs affectendocrinecomponents such asthe
estrogen receptor (34) tumor necrosis factor a (35), c-erb-a
(36), gastrin(37), and interlelukin 1,B(33). Theeffects on many
diverse endocrine systems shows asimilarity between dioxinand
endogenous hormones such asglucocorticoids. Agoodexample
of a secondary effect of dioxin on an endocrine system is the
downregulation oftheepidermal growthfactorreceptor(EGFR).
Adecrease inmembrane-bound EGFRis asensitive responseof
the liver to PCDDs and PCDFs, although it is not a result of
decreased EGFR mRNA (38). Alternatively, the decreased
membrane-associated EGFRmaybeduetointernalizationofthe
receptoras aresultofdioxin-inducedproduction ofTGF-cx, an
alternative ligandforEGFR. ThedownregulationofEGFRhas
beenimplicated inthealteredpatternsofgrowthanddifferentia-
tion characteristic ofdioxin-relatedtoxic effects. In fact, many
oftheendocrineeffectsofdioxinandrelatedcompounds, albeit
secondaryresponses, mayhaveprofoundeffectsoncelldifferen-
tiation and proliferation.
Toxicity of PCDDs and PCDFs in
Laboratory Animals
Carcinogenesis
The most common end point used in assessing the possible
human health risk to PCDDs and PCDFs is carcinogenesis in
laboratory animals following chronic exposure. The available
dataaresummarizedinTable4. Thereislittleinformationonthe
carcinogenicity ofPCDFs. 2,3,7,8-TCDD and the hexachloro-
dibenzo-p-dioxin (HCDD)mixtureactascompletecarcinogens,
producing both common and uncommon tumors at multiple
sites; dibenzo-p-dioxinand2,7-dichlorodioxinareweakornon-
carcinogens. TCDDisanextremelypotentcarcinogeninanimal
studies, producingcarcinogenic effects atdosesaslowas0.001
W/kgIday. Hepatocellularcarcinomashavealsobeenreportedin
micefortherelatedhalogenatedhydrocarbonspolybrominated
and polychlorinated biphenyls (39-41).
ThereisconsiderableevidencethatPCDDsandPCDFsdonot
act as genotoxic carcinogens. That is, TCDD andits structural
analogsdonotformcovalentDNAadducts inin vitroorin vivo
systems andarenegativeforgenetictoxicity in short-term tests
(42,43). SeveralstudieshaveshownthatTCDDactsas atumor
promoterinmultistagemodels forexperimentalcarcinogenesis
inliver(44-47)andin skin(48). Infact, TCDD is twotothree
ordersofmagnitudemorepotentthantheprototypicalpromoting
agent 12-0-tetradecanoylphorbol-13-acetate in skin (48).
Chronicbioassaysaswellastwo-stagemodelsforliveraltered-
enzyme focidemonstratethat female rats are more susceptible
toTCDD-inducedlivertumorsthanaremalerats. Recentstudies
have shown that ovarian hormones are essential to the tumor-
promoting actions of TCDD in rat liver (46). Although the
presenceoftheovaries isnecessary forthehepatocarcinogenic
effects, ovarian dependence was not observed in all tissues. In
fact, ovariectomy increasestheriskforlungtumorsasaresultof
TCDD treatment (46). Taken together, these data suggest that
tissue-specific carcinogeniceffectsofTCDD reflectacomplex
interaction with hormones and their receptors.
Noncarcinogenic End Points
Although mostregulatoryagencies userodentcarcinogenesis
as theprincipal toxic endpointby which toextrapolate human
healthrisk, manynoncarcinogeniceffectsexistandthesearenow
receiving increasedattention. Inlaboratoryanimals, TCDDand
relatedhalogenated hydrocarbonsproduce amultitude oftoxic
responses whichvarybothquantitatively andqualitatively with
thespecies, strain, and sexoftheanimalexamined. Theresults
ofenumerable studies arebriefly summarized on nextpage.
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Table 4. Carcinogenicity ofPCDDs.a
Isomer
2,3,7,8-TCDD
2,3,7,8-TCDD
2,3,7,8-TCDD
2,3,7,8-TCDD
2,3,7,8-TCDD
2,3,7,8-TCDD
2,3,7,8-TCDD
2,3,7,8-TCDD
Dibenzo-p-dioxin
2,7-DCDD
2,7-DCDD
2,7-DCDD
HCDD mixtureb
HCDD mixture
HCDD mixture
HCDD mixture
Dose
0.001 pg, 3 times perweek, skin painting
0.005 ug 3 times per week, skin painting
0.01, 0.05, 0.5 ytg/kg/week by gavage
0.01, 0.05, 0.5 Mg/kg/week by gavage
0.01, 0.05, 0.5 Mg/kg/week by gavage
0.04, 0.2, 2 Mg/kg/week by gavage
0.001, 0.01, 0.1 pg/kg,/day in diet
0.001, 0.01, 0.1 HIgkg/day in diet
5000 or 10,000 ppm indiet
5000 or 10,000 ppm indiet
5000 or 1Q000 ppm in diet
5000 or 1Q000 ppm in diet
1.5, 2.5, 5 ug/kg/week by gavage
1.5, 2.5, 5 Mg/kg/week by gavage
2.5, 5, 10 Mg/kg/week by gavage
Skin painting
Species
Male mice
Female mice
Male rats
Female rats
Male mice
Female mice
Male rats
Female rats
Rats and mice
Rats
Female mice
Male mice
Rats
Male mice
Female mice
Mice
Tumortype
None
Fibrosarcoma ofintegumetry system
Thyroid follicular cell adenoma (0.5 Mg)
Liver neoplastic nodule/carcinoma (0.5 Mg), pituitary
adenoma (0.01 pg)
Hepatocellular adenoma/carcinoma (0.5Mg), alveolar/
bronchiolar adenoma (0.5 Mg)
Hepatocellular adenoma/carcinoma (2 Mg), Thyroid folli-
cularcell adenoma (2.ug), histocytic lymphoma (2Mg)
Squamous cell carcinomaofhard palate/nasal turbinates
and tongue (0.1Ipg), adenomaofadrenal cortex (0.1 pg)
Hepatocellular hyperplastic nodules (0.01 and 0.1 g),
squamous cellcarcinoma ofhard palate/nasal turbinates
and tongue (0.1 pg), hepatocellular carcinoma (0.1 pg),
keratinizing squamous cell carcinomaoflung (0.1 pg)
None
None
None
Hepatocellular adenoma (5000 and 10,000 ppm),
leukemia/lymphoma (5000 ppm)
Hepatocellular adenoma and carcinoma/neoplastic nod-
ules (5 Mg in males, all doses infemales), follicular cell
adenoma ofthyroid (1.25 Mg, males)
Hepatocellular adenoma and carcinoma/neoplastic nod-
ules (5 Mg)
Hepatocellular adenoma and carcinoma/neoplastic nod-
ules (5 M)
None
Abbreviations: TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; DCDD, dichlorodibenzo-p-dioxin; HCDD, hexachlorodibenzo-p-dioxin.
aAdapted from Skene et al. (1).
bMixture of 1,2,3,6,7,8 and 1,2,3,7,8,9 isomers.
Table5. Toxic potency (LD5*) ofvariousPCDDs.a
LD50, ug/kg, for
Isomer Guinea pig Monkey Rat Rabbit Mouse Hamster
2,3,7,8 0.6-1 70 25-60 100 200-600 5500
1,2,3,4 - - 800 - - -
2,4,8 - - 5000 - - -
2,3,7 29,400 - - - - -
2,8 300,000 - - - - -
1,2,4,7,8 1,125 - - - - -
1,2,3,4,6,7,8,9 - - - 1000 - -
aAdapted from Vickers et al. (19).
Acute Toxicity. Certain toxic responses are consistently
observed regardless ofthe test animal studied, including pro-
gressive body weight loss and hypophagia, thymic atrophy.
(especially of the cortex), gastrointestinal hemorrhage, and
delayed lethality. The acute LD50 (dose associated with 50%
lethality) of TCDD varies over a 5000-fold range, with the
guineapigbeingthemostsensitivespeciesandthehamsterbe-
ing the leastsensitive (Table5). A similar range (103-104dif-
ference) intoxicity isobserved forotherPCDDs withthe same
general orderofspecies' sensitivity andpatternoftoxicrespon-
ses. A common characteristic ofTCDD-induced toxicity is a
pathologic "wasting syndrome," or cachexia, with reduced
feed intakeanddepletionofadiposefatstores. Thedecreasein
feed intake is not wholly responsible for the decreased body
mass and implicatesalteredenergy metabolism (49). Thecause
forthecachexiaanddelayedlethality isnotknown;however, ef-
fects on vitaminA, thyroidhormones, andtumornecrosis fac-
tor(TNF)havebeensuggestedaspossiblemediators. Recent-
lyithasbeenshownthatantibodiestoTNFcandecreaseTCDD
lethality (35).
Manypathological changes areobserved followingadminis-
trationofTCDD, including testiculardegeneration, muscular
necrosis, hepatomegaly, bileductproliferation, fattyinfiltration
oftissues, and fluorescence ofbones (indicativeofporphyrin
deposition). Theproduction ofchloracnelike lesions has been
reported in hairless mice following dermal application of
TCDD. The response of cells to PCDDs and PCDFs, i.e.,
hyperplasia versus hypoplasia, is highly species- and tissue-
sensitive. Forexample, followingexposureto TCDD, the ro-
dentliverdisplaysprimarily ahyperplastic response, whereas
thethymus showsanatropic response(19). Factorssuch as Ah
receptorconcentration, translocation, orDNAbindingsas well
as various endocrine effects of PCDDs and PCDFs, may in-
fluence thisdifferential cellular response.
194TOXICOLOGYOFPCDDsANDPCDFs
Immunotoxicity. Immunotoxicity testing with 2,3,7,8-TCDD
was initially undertaken tofurthercharacterize thelymphoidin-
volution andthymic atrophy seen ingeneral toxicity testing [for
review see Holsappleetal. (50)]. PCDDsandPCDFshaveboth
directandindirecteffectsonimmunocompetence, andtheextent
ofthe effects vary with the developmental stage ofthe animal.
Both T-cell-mediated and humoral (B cell) immunity are af-
fected. TCDD prevents thymocyte maturation andinduces ter-
minaldifferentiationofthymicepithelialcells. Theprimaryef-
fectofTCDDoncell-mediated responses maybeduetoactiva-
tionofT-suppressorcells(50). Humoral immuneresponses, i.e.,
production ofantibodies by B-cells, are affected by TCDD in
adult mice, but not in those exposedperinatally. The effect on
humoral immune responses were shown tobe adirecteffect of
the xenobiotic on B-lymphocytes.
Thedeveloping immunesystemappearstobeparticularly sen-
sitivetothesuppressiveeffectsofTCDD. Perinatal exposureto
TCDDinratsleadstoaprolongedreductionindelayedhypersen-
sitivity and lymphoproliferative responses (51). In addition,
following perinatal exposuretoTCDD, asignificantincrease in
mortality due to endotoxin administration and reduction in
plaque-forming cells wasobserved (52).
Structure-activity relationships ofPCDDs demonstrate that
effects on theimmune system parallel those ofCYPlAl induc-
tion (1). Also, 2,3,7,8-TCDFhasbeenshowntobean immuno-
suppressor in guinea pigs, although it is much weaker than
TCDD (52).
DevelopmentalandReproductive Toxicity. As stated above,
thedevelopingorganismisquitesensitivetotheeffectsofPCDDs
and PCDFs. TCDD is apotentfetotoxinandteratogen, although
there areextreme speciesdifferencesinresponses. Exposureof
mice to TCDD and related compounds results in a highly
reproducibleand characteristic teratogenic response including
hydronephrosis andcleftpalate (53). These structuralmalforma-
tions inmiceare seen atdosesmuchlowerthanneeded tocause
maternal orfetal toxicity andare someofthe mostsensitive ef-
fects known fordioxin exposure inlaboratory animals (54). In
otherlaboratoryanimalstested, TCDDcausesmaternal/fetaland
developmental toxicity butdoes notleadtoasignificantincrease
in structural abnormalities, even attoxic doses.
Workdoneprimarily withpolychlorinated biphenyls suggests
that PCDDs and PCDFs may also result in developmental
neurotoxicity (55). Exposureofbirds, rodents, andmonkeysto
complexmixturesofPCBscausespersistentchangesincognitive
behaviors suchaslearningandmemoryandalterationsintherate
ofmaturationofsensomotorreflexes inoffspring. However, itis
notknownwhichPCBs areproducingtheseeffectsandwhether
TCDD-like activity is necessary.
TCDD exposure has been shown todecrease female fertility
andgeneral reproductiveperformance (1). Although the male
reproductive system in sexually mature rats is relatively insen-
sitive to TCDD exposure, in utero and lactational exposure to
TCDD inhibits sexual differentiation of the central nervous
system (56). Exposure ofdams to low doses ofTCDD (0.064
tzg/kg) had consequences in the male pups that extended into
adulthood, including decreased sex organ weights, impaired
spermatogenesis, anddemasculinizationandfeminizationofsex-
ual behavior. Thus, the reproductive system ofthe male rat is
highly sensitive toperinatal TCDD exposure.
Toxic Equivalency Factors
Although there are extensive data on the toxicity of2,3,7,8-
T1CDD,toxicologicalinformationontheother209compoundsin
thePCDDandPCDFfamilyismuchmoresparse. Consequent-
ly,theriskassessmentofcomplex mixturesofenvironmentalcon-
taminants must be estimated based on limited experimental
information.
In 1977, DonaldGrantproposedasimpleapproachtothispro-
blemtaking intoaccountthemechanismofactionofPCDDsand
PCDFs (57). As statedabove, 2,3,7,8-TCDDandotherpolycyclic
aromatic hydrocarbons elicit their effects through interaction
withaspecificreceptor. Although2,3,7,8-TCDDisthemostpo-
tentmemberofthis family, othercompounds thatinteractwith
the Ah receptor result in similareffects, albeit athigherdoses.
GranthypothesizedthatthepotencyofPCDDsandPCDFscor-
relates with affinity for Ah receptor and early sequelae (i.e.,
CYPlAI induction). These relative potencies areexpressed as
toxicity equivalency factors (TEFs), as calculated below:
Estimated 2,3,7,8-TCDD-like toxicity ofa mixture
ofPCDDs and PCDFs
= concentration oftoxicequivalents = [TEFs]
=Ei(TEF)i x [PCDD or PCDF]i
where (TEF)i is the relative potency of the PCDD or PCDF
compared with 2,3,7,8-TCDD, i.e.,
(TEF)i = (potency ofith PCDD or PCDF).
(potency of2,3,7,8-TCDD)
AfterexaminingtherelativepotencyofdifferentPCDDsand
PCDFsforavarietyofendpointsbothin vivoandin vitro, such
ascancer, reproductiveeffects, body weightloss, cell transfor-
mation, immunotoxicity andAhreceptorbinding, asetofTEFs
hasbeenadoptedbyseveralregulatoryagencies ("1988Interna-
tionalToxic Equivalency Factors" orI-TEFs). As showninTable
6, theserelativepotenciescanbeusedtoconvertconcentrations
ofPCDDs and PCDFs found in environmental samples to the
equivalent concentration of 2,3,7,8-TCDD. For example,
2,3,7,8-TCDDis 10timesmorepotentthan2,3,7,8-TCDF assess-
edbylethality in rats. Therefore, theTEFforthisfurancongener
is0.1 "dioxinequivalents." BymultiplyingtheTEFofacongener
by itsconcentration inanenvironmental sample, anestimateof
thetoxicity canbeobtained. Inthis instance it is estimated that
0.12 pptTCDFwillhaveeffectsequivalentto0.012pptofTCDD.
The sum of the toxic equivalents for all congeners present
represents theestimated2,3,7,8-TCDD-like toxicityofamixture
ofPCDDsandPCDFs. AmajordrawbackoftheTEFapproach
isthatanassumptionismadethatallisomersfoundinamixture
haveadditiveeffects. However, several researchers haveshown
additive, synergistic, andantagonisticeffectswithinmixturesof
PCDDsorPCDFs. Also, TEFsareoftenbasedonin vitrodata,
where possible effects on the rate of clearance of isomers is
negated. For example, the rate ofclearance ofTCDF is much
more rapid than thatof1CDD. However, both congeners have
equivalentaffinity fortheAh receptor. Therefore, ifAh recep-
torbindinginvitroisthesoledeterminantofTEFcalculations,
the risk posed by TCDF would be overestimated. Despite
negativeaspectstotheuseofTEFs, theyhavebeenshowntogive
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TIble 6. Converting congener-specific source data to taic equivalents.'
Congener Concentration, pptb Toxic equivalency factor (TEF) Toxic equivalents (TEQ)
2,3,7,8-TCDD 0.11 1 0.11
1,2,3,7,8-PeCDD 0.18 0.5 0.09
1,2,3,4,7,8-HxCDD 0.08 0.1 0.008
1,2,3,6,7,8-HxCdd 0.73 0.1 0.073
1,2,3,7,8,9-HxCDD 0.15 0.1 0.015
1,2,3,4,6,7,8-HpCDD 1.3 0.01 0.013
OCDD 5.7 0.001 0.0057
Total PCDDs 0.31
2,3,7,8-TCDF 0.12 0.1 0.012
1,2,3,7,8-PeCDF 0.022 0.05 0.0011
2,3,4,7,8-PeCDF 0.51 0.5 0.26
1,2,3,4,7,8-HxCDF 0.097 0.1 0.0097
1,2,3,6,7,8-HxCDF 0.078 0.1 0.0078
2,3,4,6,7,8-HxCDF 0.04 0.1 0.004
l,2,3,4,6,7,8-HpCDF 0.19 0.01 0.0019
OCDF 0.062 0.0008 0.000052
Total PCDFs 0.30
Total TEQ 0.61
Abbreviations: T, tetra; Pe, penta; Hx, hexa; Hp, hepta; 0, octa; CDD, chlorodibenzo-p-dioxin; CDF, chlorodibenzofuran.
aAdapted from Barnes (51).
bConcentration ofPCDDs and PCDFs found in anenvironmental sample.
a fair estimate of enzyme induction by complex mixtures of
PCDDs (58). Thus, untilmoredetaileddataonthebiologicalef-
fects ofother PCDD and PCDF congeners become available,
especially within the framework ofinteractions between con-
geners,theTEFapproachisbasedonasolidscientificfoundation
andprovidesouronlymeanstoestimatethehealthriskposedby
complexmixtures ofpolychlorinated aromatic hydrocarbons.
Laboratory Animal-Human
Concordance
Although muchis knownofthebiological andtoxiceffectsof
dioxinand relatedcompoundsinexperimentalanimals, little in-
formation is available on their effects in humans. The data
availableonhumansarebasedoninvitro(i.e., inculture)aswell
as epidemiological studies. A comparison of the effects of
PCDDs and PCDFs on laboratory animals versus humans is
given in Table 7. In vitro systems such as keratinocytes or
thymocytesinculturehaveclearlyshownthatnotonlydohuman
cells possess Ah receptors, but they respond similarly to cells'
derived from rodents. Epidemiological studies suggest that
humansexposedin vivotoPCDDsandPCDFsrespondsimilarly
to experimental animals, although the data available are not
always clear.
Acomparativestudy ontheeffectsofTCDD onratliverver-
susthoseinplacentasofwomenexposedtoPCDF-contaminated
rice oil has recently been reported (59). Induction ofCYPlAl
and effects onthe epidermal growth factor receptorandgluco-
corticoid receptorwereobservedinbothspecies. Infact, humans
maybemoresensitive toeffects oftoxichalogenatedhydrocar-
bons than rats, although the correlation between these events
(i.e., CYPLAI induction)andtoxicendpointssuchascancerare
not known.
Several reports in the literature suggest that exposure of
humanstodioxinandrelatedcompoundsmaybeassociatedwith
cancer atmanydifferentsitesincluding malignantlymphomas,
softtissue sarcomas, thyroid tumors, andlungtumors(60-62).
Recently twolargecohortstudiesperformedbytheInternational
Tible 7. Similarities betweenlaboratory animalsandhumans inbiological
effects ofTCDD.'
Laboratory
Effect animals Humans
In vitro
Presence ofAh receptor + +
Enzyme induction + +
Altered patterns ofgrowth and + +
differentiation
Immunosuppression + +
Chloracnogenic response + +
In vivo
Presence ofAh receptor + +
Enzyme induction + +
Altered lipid metabolism + +
Immuneeffects + +/-
Cancer + +/-
Reproductive effects + +/-
Teratogenic effects + +/-
Altered epithelial cell differentiation + ?
Tumorpromotion + ?
'Adapted from Silbergeld and Gasiewicz (77). The (+) indicates a clear
association; (+/-)indicatesconflictingorunclearassociations; (?)indicatesthat
nothing is knownabout theeffects ofTCDD onthe system.
Agency for Research on Cancer (IARC) and the National In-
stitute ofOccupational Safety and Health (NIOSH) have been
completed. Both studies included individuals who were
suspectedtohavebeenexposedtodioxinas aresultofoccupa-
tion. An increase in thyroid tumors was noted in the IARC
registry. Increased riskofallcancerswasobservedintheNIOSH
registryaswellasincreasedriskofrespiratorytractcancer(63).
MortalityfromseveralcancersintheSevaso, Italy, areaincluding
biliarycancerhasbeenreported(64). Although severalearlier
studies showedalackoflivertumorsinhumans, themajorityof
cohorts weremale. Based ondataobtained in rats (46), tumor
formationbyTCDDispartiallydependentonovarianhormones,
andmaleratsshowrelatively fewalteredhepaticfoci. However,
TCDD-induced lung tumors are much more prevalent in male
rats. Thisincreaseinlungtumorsinmaleshasbeenreportedin
humans (64). Therefore, the human carcinogenicity data are
consistent with the rodent data presented earlier (Table 4). In
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fact, the carcinogenicity ofdioxin in rodents may help point to
cancers inhumans forfutureepidemiological examination, such
as those ofthe lung and thyroid gland.
Several noncarcinogenic effectsofPCDDSandPCDFS show
good concordance between laboratory species and humans as
well. Forexample, in laboratory animals TCDDcauses altered
intermediary metabolism manifested by changes in lipid and
glucose levels. Inalliancewiththeseresults, workersexposedto
TCDD 7-8 yearspreviously duringthemanufactureoftrichloro-
phenol showed elevated total serum triacylglycerides and
cholesterol withdecreasedhigh-densitylipoproteinconcentra-
tion [HDL(65)]. Recently, theresultsofastatistical analysisof
serumdioxinanalysisandhealtheffects inAirForcepersonnel
followingexposuretoAgentOrangewasreported(66). Signifi-
cantassociations betweenserumdioxinlevelsandseverallipid-
related variables werefound, e.g., percentbody fat,cholesterol,
triacylglycerols, and HDL. Another interesting result ofthese
studies was apositive relationshipbetweendioxinexposureand
diabetes, toourknowledgethefirstreportofsuchanassociation.
Thehuman-to-experimental animalcomparisonisconfounded
byatleasttwofactors: a)Foreverytoxiceffectproducedbydiox-
in, thereismarkedspeciesvariation. Anoutlierorhighlysuscep-
tiblespeciesforoneeffect, e.g., guineapigsforlethality ormice
forteratogenicity, may notbe anoutlierforotherresponses. b)
Humantoxicitytesting isbasedonepidemiologicaldatacompar-
ing "exposed" to "unexposed" individuals. However, as shown
inTable2, the"unexposed" cohortscontainmeasurableamounts
ofbackgroundexposuretoPCDDSandPCDFs. Also, theresults
ofmanyepidemiological studies arehamperedby small sample
size, and inmany casestheactual amountsofdioxin andrelated
compoundsinthehumantissues werenotexamined. However,
based on theavailable information, it appears that humans are
sensitivetoseveralofthetoxicefffectsofPCDDsandPCDFsand
that there is good agreement with the effects observed in
laboratory species.
Dose-Response Relationships
Receptor-Mediated Events
There is considerable controversy regarding the validity of
variousmathematical modelsusedtoestimate humanhealthrisk
todioxinsandrelatedchemicals. Forexample, theU.S. EPA(us-
ing a linearmultistage model) andCanadian Health andWelfare
Department (using a threshold model) set acceptable daily in-
takes at6 fg/kg/day and Q0000 fg/kg/day, respectively. Amazing-
ly, this enormous difference inacceptable daily intake between
theagencies isderived fromthe samedata, thatofKociba etal.
(67).
Obviously there is great need togenerate new models for risk
assessment of PCDDs and PCDFs based on the increasing
knowledgeofthe mechanismofactionofthese xenobiotics. The
centralhypothesisregardingthebiologicaleffectsofTCDDand
related chemicals is that the presence of the Ah receptor is
necessarybutnotsufficienttoresultinaresponse. Therefore, the
effects ofTCDD and related chemcials can be summarized us-
ing classical pharmacology relationships:
R + A =RA Effect
EA = [RA] [A]
Emax RT Kd + [A]
where R is the Ah receptor and A is a PCDD or PCDF. The
simplist assumption based on these relationships is that the
response is linear, i.e., response EA is directly proportional to
the fractional receptor occupancy andone-halfofthe maximal
responseoccurs atthedrugconcentrationequivalent toKd. The
logdoseversusresponsecurvesformostdrugsissigmoidal, with
an initial phase where little change in response is noted at in-
creasing drug concentration. This fact has led many to believe
thattheremustbeathresholdforthebiologicaleffectsofTCDD.
However, whenasimple relationshipbetweenreceptoroccupan-
cyandbiologicalresponseexists, thereisnothreshold. Itisalso
importanttonotethatnotallreceptor-mediated events sharethe
samedose-response characteristics. As shown inFigure4, basic
pharmacological theorydictatesthatreceptor-mediated effects
onvarioustargetorgansmaydifferinbothefficacyandpotency
ofresponse depending on many tissue-specific factors such as
receptor concentration, ligand-binding characteristics, and
recognition and binding to regulatory regions ofDNA.
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FIGURE 5. Representation ofhepatic dose-response relationships for TCDD
following chronic administration of(0-100 ng/kg/day) indiethylnitrosamine-
initiated female rats. Adapted from Tritscher et al. (68).
As shown in Figure 5, the dose-response characteristics of
chronic TCDD administration resemble those that may be
predicted fromthediscussion above. That is, CYPlAl and LA2
induction are sigmoidal and show no evidence for a threshold
(68,69). For more complex biological response, i.e., those re-
quiring multiple events such ascell proliferation orformationof
preneoplastic lesions, the dose-response curves show more
variabilityandcomplexity. Therefore, iftheinductionofCYPLAl
were used toestimate the cancer riskposedby TCDD, thenthe
acceptable daily intake (1 cancer in 106 individuals) would be
similar tothecurrent EPAstandardof0.006pg/kg/day. However,
increases in cell proliferation, possibly a better indicator of
cancer risk, are only detected at muchhigher doses than those
needed for enzyme induction. Usingcellproliferationdata, the
acceptabledaily intake may behigherthanpredictedby theU.S.
EPA.
Interindividual Variability inResponses
An important aspect ofextrapolating data to thewhole ofthe
human population is that the response to environmental con-
taminants is highly variable among individuals. Therefore, a cer-
tainpopulation may begenetically moresuceptibleto theeffects
ofPCDDs andPCDFs. The appearanceofchloracne as aresult
of dioxin exposure in humans is clearly a response with con-
siderable interindiviual variation. Forexample, inthe Sevaso in-
cident there were individuals who showed no chloracnogenic
response despite significant exposure to TCDD, while cohorts
with muchlower exposureexhibited chloracne (70). Recently in
our laboratory we have demonstrated that the induction of
CYPlAl activity in humamlymphocytesby TCDDin vitro falls
into a bimodal distribution with high-responders and low-
responders (71). This indicates that there may be genetic dif-
ferences inthecapacity ofhumancells to respondto TCDD. A
high inducibity phenotype for CYPlAl induction may be
associatedwithincreasedsusceptibility tolungcancer(71-74).
Therefore, induction of CYPlAl activity may be useful for
phenotypingsusceptibleindividuals. Interindividualdifferences
in human CYPIAI inductionby TCDDmay reflectapolymor-
phismintheCYPIAI geneaswellasdifferences intheAhrecep-
tor itself.
FutureConsiderationsand
Conclusions
TheubiquitouspresenceofPCDDsandPCDFsintheenviron-
mentand inhumantissueshasbeenamajorhealth concern for
over 20 years. Significant advancement has been made in
understanding themechanismby whichthisgroupofchemicals
producetheircharacteristic enzymeinduction. However, the use
ofthese relatively simple responses may be inappropriate for
estimating the cancer risk to these compounds. A primary
response such as enzymeinductionmay notbe themechansim
bywhichthesecompoundscausecancer. Thesequenceinevents
initated by the Ah receptor interacting with dioxin-responsive
genes and ending with altered patterns of differentiation and
growth must be sought. In this manner other surrogates for
cancerriskmaybebasedonthemechanismofthetumorigenic
responseandnotsolelyonenzymeinduction. Withaknowledge
ofthesequelaeofeventsnecessarytoproducetumors, questions
may be answered on tissue, species, sex, and interindividual
variation in biological responses to dioxin.
Available results indicate that not only does the Ah receptor
play an essential role in the toxicity of dioxin and related
chemicals, butthisreceptormayalsohavearoleincellulardif-
ferentiation (16) and possibly in wound healing (75). The
pleiotropic responseproducedbyTCDD-Ahreceptorincludes
induction of xenobiotic metabolizing enzymes (P-450 and
glutathionetransferase) aswell ascausingaltereddifferentiation
of epithelial cells. To date no endogenous ligand has been
describedfortheAhreceptor. Interestingly, severalproteinsthat
havebeenshowntobeaffectedbyTCDDhavegrowth-regulatory
functions including plasminogen activator inhibitor-2, tumor
necrosis factor-a, epidermalgrowthfactorreceptor, interleukin
1B, andtransforminggrowth factor-ca. Inaddition, theseproteins
aresecretedintothebloodstream, wherethey mayexerteffects
on cells that do not contain the Ah receptor. Dissecting the
mechanismofactionofPCDDsandPCDFsongeneregulation
mayultimately leadtoagreaterunderstandingofthe regulation
of cellular differentiation by these endogenous cytokines and
lymphokines. Despite extensive research efforts, the effects of
PCDDs and PCDFs on humans are not well characterized.
However, available data indicates that in general there is good
agreementbetweenknowneffectsofdioxininlaboratory animals
and those described in epidemiological studies for effects in
humans. Therefore, in all likelihood, dioxin and related com-
pounds do pose a threat to human health. Although the debate
over "safe" levelsofPCDDsandPCDFswillprobably continue,
thelessonslearned fromthesecompounds may haveimpacton
the regulation ofotherchemicals as well.
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